KY-Sen 2022: Charles Booker in (user search)
       |           

Welcome, Guest. Please login or register.
Did you miss your activation email?
May 14, 2024, 06:52:58 PM
News: Election Simulator 2.0 Released. Senate/Gubernatorial maps, proportional electoral votes, and more - Read more

  Talk Elections
  Other Elections - Analysis and Discussion
  Congressional Elections (Moderators: Brittain33, GeorgiaModerate, Gass3268, Virginiá, Gracile)
  KY-Sen 2022: Charles Booker in (search mode)
Pages: [1]
Author Topic: KY-Sen 2022: Charles Booker in  (Read 9684 times)
President Johnson
Atlas Star
*****
Posts: 29,077
Germany


Political Matrix
E: -3.23, S: -4.70


« on: March 15, 2021, 02:26:02 PM »

Having not voted for stimulus, Paul is vulnerable. Booker is strong candidate, running on socialist, secular, pro-stimulus platform like Fetterman who is gonna win Pennsylvania. Booker is Ds wave insurance for 54 D senate. McGrath was female running against McConnell, like Grimes, and lost. Trump is no longer on ballot and Kentucky has popular secular gov. Rs shouldn't take this for granted.

/s
Logged
President Johnson
Atlas Star
*****
Posts: 29,077
Germany


Political Matrix
E: -3.23, S: -4.70


« Reply #1 on: March 15, 2021, 03:03:07 PM »

Anyway, I hope we're not getting fooled again when the first poll comes out showing a 42-40% Paul lead and think this is anything but Safe Republican.
Logged
President Johnson
Atlas Star
*****
Posts: 29,077
Germany


Political Matrix
E: -3.23, S: -4.70


« Reply #2 on: August 12, 2021, 03:29:24 PM »

Rand Paul failed to disclose for a year that his wife purchased stock in a company that makes a COVID-19 treatment.

Quote
Kentucky Senator Rand Paul waited more than a year to disclose that his wife purchased stock in a company that makes a COVID-19 treatment, an investment made after Congress was briefed on the threat of the virus but before the public was largely aware of its danger.


The Republican filed a mandatory disclosure Wednesday revealing on Feb. 26, 2020 that Kelley Paul purchased somewhere between $1,001 and $15,000 worth of stock in Gilead, which makes the antiviral drug remdesivir. Under a 2012 law called the Stock Act, which was enacted to stop lawmakers from trading on insider information, any such sale should have been reported within 45 days.

...

The disclosure, made 16 months late, adds Paul to a growing list of lawmakers from both parties who have drawn scrutiny for their stock trading during the outbreak, which was declared a pandemic in March 2020.

In a statement, a Paul spokeswoman Kelsey Cooper said Kelley Paul used her own earnings to make the investment, which she lost money on. She said the failure by the senator, who is an eye surgeon, to disclose the trade was an oversight.


I'm tempted to move this from Safe R back to Likely R after this revelation.

Seriously? This is Safe Republican. Nobody will care in November 2022. It's a national race and it's Kentucky.
Logged
Pages: [1]  
Jump to:  


Login with username, password and session length

Terms of Service - DMCA Agent and Policy - Privacy Policy and Cookies

Powered by SMF 1.1.21 | SMF © 2015, Simple Machines

Page created in 0.02 seconds with 12 queries.